Oct 15 (Reuters) -
- LAUNCHES FEDERAL COURT ACTION AND CALLS ON GENERAL INSURERS TO REVIEW PRICING PRACTICES
- LAUNCHED CIVIL PENALTY PROCEEDINGS IN COURT AGAINST INSURANCE AUSTRALIA FOLLOWING FAILURE TO HONOUR DISCOUNT PROMISES MADE TO ITS CUSTOMERS
- ALLEGES THAT THIS PRACTICE IMPACTED NRMA INSURANCE RENEWALS BETWEEN MARCH 2014 AND NOVEMBER 2019 AND AFFECTED AT LEAST 596,000 CUSTOMERS
- ALLEGES THAT IAL ENGAGED IN MISLEADING OR DECEPTIVE CONDUCT AND MADE FALSE OR MISLEADING REPRESENTATIONS TO SOME NRMA INSURANCE CUSTOMER
- AFFECTED CUSTOMERS DID NOT RECEIVE PROMISED DISCOUNTS TOTALLING AROUND A$60 MILLION
- CLAIMS IAL INCREASED GROSS INSURANCE PREMIUMS THAT WOULD APPLY TO CUSTOMERS TO ENSURE THEIR NET PREMIUMS AFTER DISCOUNTS DID NOT FALL BELOW CERTAIN LEVEL
[ ] (([email protected];))
- Forums
- ASX - By Stock
- IAG
- News: IAG Australia's ASIC Launches Court Action & Calls On General Insurers To Review Pricing...
IAG
insurance australia group limited
Add to My Watchlist
0.40%
!
$8.79

News: IAG Australia's ASIC Launches Court Action & Calls On General Insurers To Review Pricing...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.79 |
Change
0.035(0.40%) |
Mkt cap ! $20.67B |
Open | High | Low | Value | Volume |
$8.70 | $8.81 | $8.69 | $6.408M | 754.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 4586 | $8.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.79 | 4831 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 604 | 8.780 |
26 | 12321 | 8.770 |
15 | 7628 | 8.760 |
13 | 8134 | 8.750 |
13 | 20521 | 8.740 |
Price($) | Vol. | No. |
---|---|---|
8.790 | 6014 | 16 |
8.800 | 8751 | 12 |
8.810 | 18785 | 12 |
8.820 | 27281 | 10 |
8.830 | 75612 | 8 |
Last trade - 11.14am 22/08/2025 (20 minute delay) ? |
Featured News
IAG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online